Upgrade to SI Premium - Free Trial

MeiraGTx Holdings plc (MGTX)

9.14 -0.07 (0.76%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 MeiraGTx Holdings plc For: Jun 10 Filed by: Harris Keith R. June 10, 2026 8:01 PM - SEC Filing Form 4 MeiraGTx Holdings plc For: May 27 Filed by: Giroux Richard May 28, 2026 9:04 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on MeiraGTx Holdings plc (MGTX) May 26, 2026 6:53 AM - StreetInsider Form 4 MeiraGTx Holdings plc For: May 19 Filed by: Forbes Alexandria May 19, 2026 9:05 PM - SEC Filing Form 144 MeiraGTx Holdings plc Filed by: Forbes Alexandria May 19, 2026 9:04 PM - SEC Filing MeiraGTx Holdings plc (MGTX) PT Raised to $25 at RBC Capital May 15, 2026 7:38 AM - StreetInsider Form 4 MeiraGTx Holdings plc For: May 13 Filed by: Fleck Penny Renee May 14, 2026 9:07 PM - SEC Filing Form 3 MeiraGTx Holdings plc For: May 11 Filed by: Fleck Penny Renee May 14, 2026 9:01 PM - SEC Filing MeiraGTx Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) May 14, 2026 4:30 PM - StreetInsider MeiraGTx Holdings plc (MGTX) Tops Q1 EPS by 5c May 14, 2026 8:31 AM - StreetInsider Form 10-Q MeiraGTx Holdings plc For: Mar 31 May 14, 2026 8:31 AM - SEC Filing Form 8-K MeiraGTx Holdings plc For: May 14 May 14, 2026 8:06 AM - SEC Filing MeiraGTx Reports First Quarter 2026 Financial and Operational Results May 14, 2026 8:00 AM - Globe NewsWire Form SCHEDULE 13G/A MeiraGTx Holdings plc Filed by: Adage Capital Management, L.P. May 13, 2026 9:08 AM - SEC Filing Form ARS MeiraGTx Holdings plc For: Dec 31 April 30, 2026 8:19 AM - SEC Filing Form DEFA14A MeiraGTx Holdings plc April 30, 2026 8:14 AM - SEC Filing Form DEF 14A MeiraGTx Holdings plc For: Jun 11 April 30, 2026 8:07 AM - SEC Filing Form 4/A MeiraGTx Holdings plc For: Jan 07 Filed by: Zeldin Robert K April 28, 2026 9:05 PM - SEC Filing Form SCHEDULE 13D/A MeiraGTx Holdings plc Filed by: PERCEPTIVE ADVISORS LLC April 24, 2026 4:47 PM - SEC Filing Form 8-K MeiraGTx Holdings plc For: Apr 20 April 24, 2026 8:35 AM - SEC Filing Form 4 MeiraGTx Holdings plc For: Aug 02 Filed by: EDELMAN JOSEPH April 23, 2026 8:59 PM - SEC Filing MeiraGTx Holdings plc (MGTX) PT Raised to $30 at Piper Sandler 'Remain Buyers' April 22, 2026 9:23 AM - StreetInsider Form 4 MeiraGTx Holdings plc For: Apr 21 Filed by: Giroux Richard April 21, 2026 9:01 PM - SEC Filing Form 144 MeiraGTx Holdings plc Filed by: Giroux Richard April 21, 2026 9:00 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on MeiraGTx Holdings plc (MGTX) April 20, 2026 6:35 AM - StreetInsider MeiraGTx Holdings plc (MGTX) PT Raised to $24 at RBC Capital April 17, 2026 5:08 AM - StreetInsider Form 424B5 MeiraGTx Holdings plc April 16, 2026 5:26 PM - SEC Filing Form 8-K MeiraGTx Holdings plc For: Apr 16 April 16, 2026 5:26 PM - SEC Filing MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares April 16, 2026 11:42 AM - Globe NewsWire MeiraGTx prices $100 million share offering at $9.00 per share April 16, 2026 7:50 AM - StreetInsider MeiraGTx Announces Pricing of $100 Million Offering of Ordinary Shares April 16, 2026 7:49 AM - StreetInsider Form 8-K MeiraGTx Holdings plc For: Apr 15 April 16, 2026 7:17 AM - SEC Filing MeiraGTx acquires gene therapy bota-vec from Johnson & Johnson April 16, 2026 7:10 AM - StreetInsider MeiraGTx Announces the Acquisition of Botaretigene Sparoparvovec (bota-vec) for the Treatment of X-linked Retinitis Pigmentosa (XLRP) April 16, 2026 7:10 AM - StreetInsider Form 8-K MeiraGTx Holdings plc For: Apr 16 April 16, 2026 7:09 AM - SEC Filing MeiraGTx reports sustained benefits from gene therapy trial at 3 years April 16, 2026 7:01 AM - StreetInsider MeiraGTx Announces Positive Three-year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Late Radiation-Induced Xerostomia April 16, 2026 7:00 AM - Globe NewsWire MeiraGTx to present 3-year data from gene therapy xerostomia study April 14, 2026 8:31 AM - StreetInsider MeiraGTx to Present 3-Year Data from the Phase 1 AQUAx Clinical Study of AAV-hAQP1 for the Treatment of Grade 2/3 Radiation-Induced Xerostomia on Thursday, April 16, 2026 April 14, 2026 8:30 AM - Globe NewsWire Form 4 MeiraGTx Holdings plc For: Apr 07 Filed by: Naylor Stuart April 7, 2026 8:58 PM - SEC Filing Form 144 MeiraGTx Holdings plc Filed by: Naylor Stuart April 7, 2026 4:17 PM - SEC Filing Form 10-K MeiraGTx Holdings plc For: Dec 31 March 30, 2026 8:14 AM - SEC Filing MeiraGTx Holdings plc (MGTX) PT Lowered at Piper Sandler; 'We see meaningful upside to the stock' March 27, 2026 9:30 AM - StreetInsider MeiraGTx Holdings plc (MGTX) PT Raised to $16 at BofA Securities March 26, 2026 5:24 PM - StreetInsider MeiraGTx Holdings plc (MGTX) PT Lowered to $27 at Raymond James March 26, 2026 11:51 AM - StreetInsider Form 8-K MeiraGTx Holdings plc For: Mar 25 March 26, 2026 8:25 AM - SEC Filing MeiraGTx receives FDA breakthrough therapy designation for xerostomia treatment March 26, 2026 8:00 AM - StreetInsider MeiraGTx Announces FDA Breakthrough Therapy Designation for AAV2-hAQP1 for the Treatment of Grade 2 and Grade 3 Radiation-Induced Xerostomia (RIX) and Reports Fourth Quarter and Full Year 2025 Financi March 26, 2026 8:00 AM - StreetInsider Form 4 MeiraGTx Holdings plc For: Mar 24 Filed by: Forbes Alexandria March 24, 2026 9:13 PM - SEC Filing Form 144 MeiraGTx Holdings plc Filed by: Forbes Alexandria March 24, 2026 9:11 PM - SEC Filing Full Article List